Stretch Marks
Peptides explored for stretch marks — GHK-Cu, Matrixyl, copper peptides — with mechanism rationale for collagen and elastin remodeling, evidence in striae treatment, and how peptide therapy fits alongside retinoids and procedural care.
Stretch marks (striae distensae) are linear depressions of the skin that form when skin is stretched beyond its elastic capacity, leading to disruption of collagen and elastin in the dermis. They commonly form during pregnancy (striae gravidarum), rapid weight gain or loss, adolescent growth spurts, bodybuilding, prolonged corticosteroid use, and certain endocrine conditions (Cushing's, Marfan syndrome). Striae progress through stages: striae rubra (red/pink, recently formed) and striae alba (white, mature, atrophic). Once mature, stretch marks are essentially atrophic scars and are notoriously difficult to fully eliminate.
Conventional management is multimodal with limited efficacy: topical retinoids (particularly tretinoin) for striae rubra during the inflammatory window; hyaluronic acid; topical onion extract (Mederma); microneedling with or without radiofrequency; fractional laser resurfacing; PRP combined with microneedling; chemical peels; and combination protocols. None of these produce dramatic clearance, particularly for mature striae alba. Prevention through gradual weight changes and adequate hydration during pregnancy or rapid growth is more impactful than treatment of established marks.
Peptide therapy has come up in cosmetic dermatology for stretch marks, primarily through GHK-Cu (well-established skin remodeling peptide), Matrixyl (palmitoyl pentapeptide-4, a collagen-stimulating peptide), and other peptides marketed for collagen synthesis. The evidence base is largely cosmetic-product-driven rather than rigorous dermatological RCT, but the mechanism is mechanistically aligned with the underlying biology of striae. The honest framing: peptides may add modest improvement to comprehensive striae protocols, but they do not produce dramatic clearance, particularly of mature striae alba.
This page covers what's actually known about peptides for stretch marks, where the evidence is strongest, how peptide therapy fits alongside conventional and procedural care, and important caveats. It is informational, not medical advice.
Peptides discussed for Stretch Marks
GHK-Cu
Copper Peptide
The most-studied copper peptide in skincare — a naturally occurring tripeptide (GHK, Gly-His-Lys) whose active tissue form is the copper complex GHK-Cu, with extensive evidence for skin remodeling, collagen synthesis, wound healing, and anti-aging.
Matrixyl
Signal Peptide (Cosmetic)
A collagen-stimulating cosmetic peptide that signals skin to produce more collagen and extracellular matrix proteins.
Palmitoyl Tripeptide-1
Signal Peptide (Cosmetic)
A collagen-boosting cosmetic peptide that mimics the body's wound-healing signal to stimulate collagen and elastin production in the skin.
AHK-Cu
Copper Peptide
A copper peptide — the copper-complexed tripeptide alanine-histidine-lysine (AHK-Cu, Copper Tripeptide-3) — studied for hair follicle stimulation and dermal papilla cell survival. A structural cousin of the better-known copper peptide GHK-Cu with a distinct, hair-focused research profile.
Syn-Coll
Cosmeceutical Peptide
A synthetic signal peptide that mimics thrombospondin-1 to activate TGF-beta signaling, stimulating type I and III collagen production in dermal fibroblasts for anti-wrinkle and skin-firming effects.
How peptides target stretch marks
GHK-Cu (glycyl-L-histidyl-L-lysine-copper) is the most-discussed peptide for stretch marks. Its mechanism — activation of fibroblast collagen synthesis (type I and type III collagen), stimulation of glycosaminoglycan production, modulation of matrix metalloproteinases, and copper-driven lysyl oxidase crosslinking that gives repaired collagen its tensile strength — aligns directly with the dermal repair needs of stretch marks. The collagen and elastin disruption underlying striae is exactly the matrix biology GHK-Cu addresses. Topical GHK-Cu has been used as an adjunct in striae protocols for many years.
Matrixyl (palmitoyl pentapeptide-4) is a synthetic peptide developed for collagen stimulation. It is marketed as a tetrapeptide signal that mimics fragments of collagen breakdown, signaling fibroblasts to synthesize new collagen. Multiple cosmetic dermatology studies have demonstrated collagen synthesis effects in skin. Matrixyl is widely used in anti-aging skincare and has secondary application to striae treatment.
Oligopeptide-1 and palmitoyl tripeptide-1 are similar synthetic peptides marketed for collagen stimulation in cosmetic skincare contexts. Their evidence base is largely cosmetic-product-driven.
What peptides do not do for stretch marks: produce dramatic clearance of mature striae alba (the white, atrophic, mature form is essentially scar tissue with permanent collagen disorganization that no topical intervention fully reverses); replace procedural therapies (microneedling, laser) for significant improvement; address the underlying mechanisms that drive striae formation (skin stretch beyond elastic capacity, hormonal factors, genetic predisposition).
What the evidence shows
Peptide-specific evidence in stretch marks is limited. GHK-Cu has substantial general skin-remodeling evidence with secondary application to striae. Matrixyl has cosmetic dermatology trials demonstrating collagen synthesis effects, though striae-specific RCTs are limited. Most peptide products marketed for stretch marks rely on cosmetic-product testing rather than rigorous dermatological RCT.
For evidence-validated striae therapy, the trial base shows uniformly modest results. Tretinoin has the strongest evidence for striae rubra in particular. Microneedling and fractional laser have moderate evidence for partial improvement. Combination protocols (peptides + retinoids + procedural therapy) often outperform any single intervention. Mature striae alba show poor response to most interventions; aggressive procedural therapy with multiple sessions over months can produce visible improvement but not full clearance.
Peptide therapy is reasonable as an adjunct in comprehensive striae protocols. The evidence for substantial standalone benefit is limited.
What to expect
Topical peptide therapy (GHK-Cu, Matrixyl) for stretch marks typically requires 8-16 weeks of consistent application before visible improvement. Improvement is gradual and modest. Striae rubra (recent, red/pink) respond better than striae alba (mature, white). Combination protocols (peptide + retinoid + microneedling) typically outperform any single intervention.
What to NOT expect: complete clearance of mature stretch marks, dramatic improvement comparable to laser resurfacing alone, visible results from short courses (less than 8 weeks). Stretch marks once mature are essentially atrophic scars; significant improvement of mature striae usually requires aggressive multi-session procedural therapy and even then is partial.
Important caveats
Pregnancy and breastfeeding are relevant safety considerations for stretch mark treatment — pregnancy-related striae often improve postpartum, and aggressive treatment is typically deferred until breastfeeding ends. Topical retinoids are contraindicated in pregnancy and breastfeeding. Topical peptides are generally considered low-risk in these populations but specific safety data is limited.
New or rapidly forming stretch marks in patients without obvious explanation (no pregnancy, no significant weight change, no rapid growth) can suggest endocrine disorders (Cushing's syndrome) or connective tissue disorders (Marfan syndrome), and warrant evaluation rather than cosmetic treatment.
None of the peptides discussed is FDA-approved as a drug for stretch marks. Topical peptide formulations are cosmetic products. The realistic framing: striae are difficult to treat, with all interventions producing modest improvement; comprehensive multi-modal protocols (peptides + retinoids + procedural therapy) generally outperform single interventions.
Frequently asked questions
Can peptides remove stretch marks?
No. Stretch marks once mature are essentially atrophic scars with permanent collagen disorganization. Peptides like GHK-Cu and Matrixyl can support collagen synthesis and modest improvement, particularly in striae rubra (recent, red/pink stretch marks), but they do not produce complete clearance. Aggressive multi-session procedural therapy (microneedling, fractional laser) combined with topical peptides and retinoids generally produces the best results, but full clearance of mature stretch marks is rarely achievable.
What is the best peptide for stretch marks?
GHK-Cu has the most established skin-remodeling profile and is the most-discussed peptide for stretch marks. Matrixyl (palmitoyl pentapeptide-4) is widely used in anti-aging skincare with collagen-stimulating effects applicable to striae. Combination protocols using both, alongside retinoids and procedural therapy, typically outperform any single peptide.
Will GHK-Cu work on old white stretch marks?
Less effectively than on recent red stretch marks. Mature striae alba (white, atrophic) have permanent collagen disorganization that topical interventions only partially address. GHK-Cu may provide modest improvement over months of consistent use, particularly when combined with microneedling or laser therapy. Realistic expectation: gradual partial improvement, not clearance.
Are peptides safe during pregnancy for stretch marks?
Topical peptides are generally considered low-risk in pregnancy with limited specific safety data. Topical retinoids (the most evidence-validated stretch mark treatment for striae rubra) are contraindicated in pregnancy. Many pregnancy-related stretch marks improve spontaneously postpartum. Aggressive treatment is typically deferred until after breastfeeding. Discuss specific products with an obstetrician or dermatologist familiar with pregnancy safety.
How long do peptides take to work on stretch marks?
Topical peptide therapy for stretch marks typically requires 8-16 weeks of consistent application before visible improvement, with continued benefit accruing over 6-12 months. Improvement is modest and gradual. Combination with retinoids (in non-pregnancy/non-breastfeeding patients) and procedural therapy substantially improves outcomes over peptides alone.
Part of these goals
Related conditions
Peptide families relevant to Stretch Marks
Cosmetic & Signal Peptides
The cosmetic peptide actives applied topically for skin aging, wrinkles, and pigmentation — including argireline (acetyl hexapeptide-8, the SNAP-25-targeting 'topical Botox' analog), matrixyl (palmitoyl pentapeptide-4, the matrikine collagen stimulator), syn-ake (the snake-venom-derived nicotinic-receptor antagonist), SNAP-8, vialox, rigin, and the broader cluster of palmitoylated tripeptides, palmitoylated tetrapeptides, and signal peptides used in cosmetic formulations.
Collagen Peptides
Two distinct meanings of 'collagen peptide' that consumer marketing often conflates: (1) oral hydrolyzed-collagen protein supplements (gelatin-derived powders sold for skin, hair, and joint health) with modest RCT support for skin elasticity and moisture, and (2) cosmetic 'matrikine' peptides (Matrixyl, syn-coll, palmitoyl-tripeptide-1, GHK-Cu) that stimulate fibroblast collagen synthesis topically. Different molecules, different routes, different evidence bases.
Copper Peptides
A family of small copper-binding tripeptides — GHK-Cu, AHK-Cu, and palmitoyl variants — that form stable copper(II) complexes with documented effects on collagen synthesis, wound healing, and skin remodeling. Founded by Loren Pickart's 1973 isolation of GHK-Cu and now a fixture of cosmetic dermatology and the wound-care literature.
Updated 2026-05-08